Rubric Capital Management LP 13D and 13G filings for Sutro Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-13 4:30 pm Sale |
2024-09-30 | 13G | Sutro Biopharma, Inc. STRO |
Rubric Capital Management LP | 0 0.000% |
-3,344,810 (Position Closed) |
Filing |
| 2024-02-12 06:06 am Purchase |
2023-12-31 | 13G | Sutro Biopharma, Inc. STRO |
Rubric Capital Management LP | 3,344,810 5.490% |
132,938 (+4.14%) |
Filing |
| 2023-02-10 4:00 pm Purchase |
2022-12-31 | 13G | Sutro Biopharma, Inc. STRO |
Rubric Capital Management LP | 3,211,872 5.590% |
3,211,872 (New Position) |
Filing |